Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Meissner Corporation Invests US$250 million to Construct New Manufacturing Facility
Meissner Corporation plans to construct new manufacturing facility The new facility will be loacted at Georgia, USA
Cambrex Constructs New Stability Storage Facility in Belgium, Europe
Cambrex plans to construct new stability storage facility to the pharmaceutical, medical device and life sciences industries across Europe
Catalent Invests US$20 million to Expand in Schorndorf, Germany
Introduction Catalent invests US$20 million to expand its clinical supply facility The new facility will be located in Schorndorf, Germany
PharmaBlock Plans to Expand New R&D Facility Operations in Pennsylvania, USA
PharmaBlock plans to expand its RD operations to deliver GMP projects with the opening of new facility
Pharmaron Invests US$189.79 million (£151 million) to Open New Manufacturing Facility in UK
Pharmaron plans to open a new gene production facility to expand its viral vector and DNA manufacturing facilities to more than 8,000 square metres
Evonik Constructs New Pharmaceutical Lipids Facility in Indiana, USA
Evonik with an investment of US$220 million plans for the construction of new pharmaceutical lipid production facility The new facility will be located in Indiana, United States The new facility is expected to provide industry with access to critical adjuvants needed for mRNA vaccines and other nucleic acid therapies
Samsung Biologics Invests US $1.46 billion (KRW 1.9 trillion) for the Construction of Fifth New Plant
Samsung Biologics plans for the contruction of fifth new plant The new site will be located at Songdo, South Korea The new facility is the second Bio campus covering an area of 96,000m2 and holding a capacity of 180,000 litres
AtomVie Global Radiopharma to Open New Radiotherapeutics Facility in Ontario, Canada
AtomVie Global Radiopharma in partnership with Panattoni Development plans for the construction of new stateoftheart radiotherapeutics facility The new stateoftheart facility which covers an area of 64,000 square feet is is designed for largescale clinical and commercial GMP
Fluor Corporation Invests US$725 million to Open New Manufacturing Facility
Fluor Corporation plans to open new oligonucleotide therapeutics manufacturing facility The new facility will be located in Colorado, USA The manufacturing facility laid at 275,000 squarefoot will house two manufacturing lines to double manufacturing capability
Agilent Technologies Constructs New Manufacturing Facility in Frederick, USA
Agilent Technologies plans to double its manufacturing capacity of therapeutic nucleic acids The new nucleic acid contract development and manufacturing services offer superior customer service, the highest quality oligo API material, and cGMP Current Good Manufacturing Practices to produce highvolume oligos efficiently and costeffectively from ear...
